ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 1( 28)’ 2017
carcinoma // N. Engl. J. Med.— 1998.— 338.— P. 297-306.
4. Mazzaferri E. L. et al. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer // Am. J. Med.— 1994.— 97.— P. 418-428.
5. Kitamura Y., Shimizu K. et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal case // J. Clin. Endocrinol. Metab.— 2001.— 84.— P. 656-658.
6. Durante et al. Long term outcome of 444patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy // J. Clin. Endocrinol. Metab.— 2006.— 91.— P. 2892-2899.
7. Bernier M. O., Leenhardt L., Hoang C. et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas // J. Clin. Endocrinol. Metab.— 2001.— 86.— P. 1568-1573.
40 Клинические исследования и опыт в онкологии